Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment | NCT01145144 | Trialant
CompletedInterventionalNot ApplicableUpdated Jun 16, 2010
Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment
ClinicalTrials.gov ID
NCT01145144
Lead Sponsor
Meir Medical CenterOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Last Update Posted
Jun 16, 2010Estimated
Start Date
Jan 2008
Primary Completion Date
Jul 2009Actual
Completion Date
Jul 2009Actual
Brief Summary
The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.
Ovarian Stimulation
dehydroepiandrosterone crystalline fine powder
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
previous poor response to ovarian stimulation in IVF.